Your browser doesn't support javascript.
loading
A case study of spironolactone induced gynecomastia in one male patient with cir-rhosis / 药学实践杂志
Journal of Pharmaceutical Practice ; (6): 165-166,170, 2017.
Article de Zh | WPRIM | ID: wpr-790724
Bibliothèque responsable: WPRO
ABSTRACT
Objective To study one male patient with cirrhosis for spironolactone induced gynecomastia and promote clinical pharmacists providing better pharmaceutical cares .Methods Based on the patient′s diseases and medication history , clinical pharmacists searched related literature and analyzed the cause of gynecomastia for the patient .Results The patient′s breast pain was relieved and finally disappeared after termination of spironolactone .Therefore ,spironolactone was suspected to be the drug to cause gynecomastia .Conclusion Clinical pharmacists can improve pharmaceutical cares by carefully monitoring the adverse reactions and selecting appropriate medications .
Mots clés
Texte intégral: 1 Base de données: WPRIM Langue: Zh Journal: Journal of Pharmaceutical Practice Année: 2017 Type de document: Article
Texte intégral: 1 Base de données: WPRIM Langue: Zh Journal: Journal of Pharmaceutical Practice Année: 2017 Type de document: Article